2022
Genetic testing in privately insured women with surgically treated breast cancer
Dinan M, Pitafi S, Greenup R, Long J, Gross C. Genetic testing in privately insured women with surgically treated breast cancer. Breast Cancer Research And Treatment 2022, 198: 177-181. PMID: 36542252, DOI: 10.1007/s10549-022-06829-4.Peer-Reviewed Original ResearchConceptsBreast cancerGenetic testingRoutine breast cancer careBRCA1/BRCA2 genetic testingHormone receptor statusBreast cancer careInvasive breast cancerBRCA2 genetic testingReceptor statusWomen 50Cancer careAge 45Family historyOlder womenInsurer databaseYoung womenCancerWomenCoverage policiesUnclear implicationsPatientsSurgeryPurposeRatesYearsPrevalence
1999
The Relation between Funding by the National Institutes of Health and the Burden of Disease
Gross C, Anderson G, Powe N. The Relation between Funding by the National Institutes of Health and the Burden of Disease. New England Journal Of Medicine 1999, 340: 1881-1887. PMID: 10369852, DOI: 10.1056/nejm199906173402406.Peer-Reviewed Original ResearchMeSH KeywordsBiomedical ResearchCost of IllnessCross-Sectional StudiesDiseaseFederal GovernmentHealth Care RationingHospitalizationHumansMorbidityMortalityNational Institutes of Health (U.S.)Quality-Adjusted Life YearsResearch Support as TopicResource AllocationSickness Impact ProfileSocial ChangeSocial ValuesUnited StatesConceptsBurden of diseaseYears of lifeHospital daysChronic obstructive pulmonary diseaseDisease-specific fundingObstructive pulmonary diseaseCross-sectional studyNational InstituteNIH fundingInstitute of MedicineNumber of deathsDiabetes mellitusPulmonary diseaseImmunodeficiency syndromePeptic ulcerPerinatal conditionsBreast cancerTotal mortalityDiseaseBurdenRegression analysisPrevalenceIncidenceHealthDays